Đang chuẩn bị liên kết để tải về tài liệu:
RhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) reduces neutropenia events and is widely used in cancer patients receiving chemotherapy. However, the effects of rhG-CSF on distant organ metastasis (DOM) in non-small-cell lung cancer (NSCLC) patients following postoperative chemotherapy are not clear. |